Trelegy Ellipta Evropska unija - slovenščina - EMA (European Medicines Agency)

trelegy ellipta

glaxosmithkline trading services - flutikazon furoat, umeclidinium bromid, vilanterol trifenatat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - trelegy ellipta je označen kot vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana s kombinacijo inhalacijski kortikosteroidi in dolgotrajnim delovanjem β2-agonist.

Mifegyne 200 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mifegyne 200 mg tablete

nordic group bv - mifepriston - tableta - mifepriston 200 mg / 1 tableta - mifepriston

Caelyx pegylated liposomal Evropska unija - slovenščina - EMA (European Medicines Agency)

caelyx pegylated liposomal

baxter holding b.v. - doksorubicinijev klorid - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - antineoplastična sredstva - caelyx pegylated liposomal je navedeno:kot monotherapy za bolnike z metastatskim rakom dojke, kjer je povečana srčna tveganja;za zdravljenje advanced rak na jajčnikih pri ženskah, ki niso uspeli v prvi vrstici platinum, ki temelji kemoterapijo režim;v kombinaciji z bortezomib za zdravljenje postopno več plazmocitom pri bolnikih, ki so prejeli vsaj en pred terapijo in ki so že obdelani ali ki so neprimerni za presaditev kostnega mozga;za zdravljenje hiv kaposi ' s sarkom (ks) pri bolnikih z nizko cd4 šteje (.

Zolsketil pegylated liposomal Evropska unija - slovenščina - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Celdoxome pegylated liposomal Evropska unija - slovenščina - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

INEGY 10 mg/40 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inegy 10 mg/40 mg tablete

merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta  simvastatin40 mg / 1 tableta; simvastatin 40 mg / 1 tableta - simvastatin in ezetimib

INEGY 10 mg/20 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inegy 10 mg/20 mg tablete

merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta  simvastatin20 mg / 1 tableta; simvastatin 20 mg / 1 tableta - simvastatin in ezetimib

INEGY 10 mg/10 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inegy 10 mg/10 mg tablete

merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta  simvastatin10 mg / 1 tableta; simvastatin 10 mg / 1 tableta - simvastatin in ezetimib

INEGY 10 mg/40 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inegy 10 mg/40 mg tablete

merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta  simvastatin40 mg / 1 tableta; simvastatin 40 mg / 1 tableta - simvastatin in ezetimib

INEGY 10 mg/80 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inegy 10 mg/80 mg tablete

merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta  simvastatin80 mg / 1 tableta; simvastatin 80 mg / 1 tableta - simvastatin in ezetimib